MedCity Influencers

MELA

I have been following the FDA approval of MELA, maker of a device for quantifying the risk of a melanoma via a dual wavelength “gun” that can see below the skin. It seems like a very viable device to me, but I was wondering of there is anyone with experience or thoughts on how this […]

I have been following the FDA approval of MELA, maker of a device for quantifying the risk of a melanoma via a dual wavelength “gun” that can see below the skin. It seems like a very viable device to me, but I was wondering of there is anyone with experience or thoughts on how this would be accepted?

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.